TRAVERE THERAPEUTICS INC. - COMMON STOCK
18.25
22-نوفمبر-24 16:44:58
15 متأخرة بدقائق
الأسهم
-0.01
-0.05%
نطاق اليوم
18.03 - 18.93
ISIN
N/A
المصدر
NASDAQ
-
Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference
02 يونيو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Presentations of Abstracts at the 59th ERA Congress
17 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
16 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 مايو 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports First Quarter 2022 Financial Results
05 مايو 2022 16:01:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
03 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Report First Quarter 2022 Financial Results
28 أبريل 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Plan for Chief Financial Officer Transition
20 أبريل 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 أبريل 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
06 أبريل 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
21 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 مارس 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Prices Upsized $275 Million Convertible Senior Notes Offering
08 مارس 2022 21:00:26 بحسب Nasdaq GlobeNewswire
-
Travere Announces Proposed Convertible Senior Notes Offering
08 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
03 مارس 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
28 فبراير 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
24 فبراير 2022 16:01:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 فبراير 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
10 فبراير 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09 فبراير 2022 16:30:00 بحسب Nasdaq GlobeNewswire